TY - JOUR
T1 - Baerveldt glaucoma implant insertion in the posterior chamber sulcus
AU - Tello, Celso
AU - Espana, Edgar M.
AU - Mora, Ricardo
AU - Dorairaj, Syril
AU - Liebmann, Jeffrey M.
AU - Ritch, Robert
PY - 2007/6
Y1 - 2007/6
N2 - Aim: To report the clinical outcome of a surgical technique for insertion of the silicone tube of a Baerveldt glaucoma implant (BGI) in the posterior chamber sulcus. Methods: Non-comparative, interventional case series. Eight eyes of eight patients, with a follow-up of at least 18 months, who underwent insertion of a BGI with the silicone tube placed in the posterior chamber sulcus between 1998 and 2005 were included. Control of intraocular pressure (IOP), number of pressure-lowering medications, visual acuity and surgical complications were recorded. Results: Eight eyes of eight patients (mean (range) age 76.4 (62-94) years) were included in the study. The IOP was reduced from a preoperative mean (SD) of 28.2 (14.4) to 12.6 (5.8) mm Hg at 18 months. The mean (SD) number of preoperative medications for IOP control was reduced from 2.8 (1.5) to 1.3 (1.5) medications in the same period. No complications were observed during surgery or follow-up. Conclusion: Placement of the silicone tube in the posterior chamber sulcus is a safe and effective alternative technique for IOP control in patients with pseudophakia. Sulcus placement may reduce the likelihood of corneal endothelial loss and avoid the need for pars-plana vitrectomy and posterior segment tube insertion in complicated eyes.
AB - Aim: To report the clinical outcome of a surgical technique for insertion of the silicone tube of a Baerveldt glaucoma implant (BGI) in the posterior chamber sulcus. Methods: Non-comparative, interventional case series. Eight eyes of eight patients, with a follow-up of at least 18 months, who underwent insertion of a BGI with the silicone tube placed in the posterior chamber sulcus between 1998 and 2005 were included. Control of intraocular pressure (IOP), number of pressure-lowering medications, visual acuity and surgical complications were recorded. Results: Eight eyes of eight patients (mean (range) age 76.4 (62-94) years) were included in the study. The IOP was reduced from a preoperative mean (SD) of 28.2 (14.4) to 12.6 (5.8) mm Hg at 18 months. The mean (SD) number of preoperative medications for IOP control was reduced from 2.8 (1.5) to 1.3 (1.5) medications in the same period. No complications were observed during surgery or follow-up. Conclusion: Placement of the silicone tube in the posterior chamber sulcus is a safe and effective alternative technique for IOP control in patients with pseudophakia. Sulcus placement may reduce the likelihood of corneal endothelial loss and avoid the need for pars-plana vitrectomy and posterior segment tube insertion in complicated eyes.
UR - http://www.scopus.com/inward/record.url?scp=34249781397&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34249781397&partnerID=8YFLogxK
U2 - 10.1136/bjo.2006.107839
DO - 10.1136/bjo.2006.107839
M3 - Article
C2 - 17301121
AN - SCOPUS:34249781397
SN - 0007-1161
VL - 91
SP - 739
EP - 742
JO - British Journal of Ophthalmology
JF - British Journal of Ophthalmology
IS - 6
ER -